Herpes Simplex Virus Treatment with Antimicrobial Peptides

Leonid V. Kovalchuk1, Ludmila V. Gankovskaya1, Oksana A. Gankovskaya2, and Vyacheslav F. Lavrov2

1 Russian State Medical University, Department of Immunology, Moscow, Russia

2 Mechnikov Research Institute of Vaccines and Sera, Department of Viral Infection Diagnostics Moscow, Russia, [email protected]

Abstract. The herpes virus infection represents a significant challenge for public health. The innate immunity plays an important role in herpes simplex virus (HSV) elimination. The innate antiviral immunity has not been comprehensively studied. The recent investigations demonstrate that Toll-like receptors are actively involved in the virus recognition. The complement and natural antibodies, as well as cytokines and antimicrobial peptides, are the first molecules to bind to virions. In this chapter, some mechanisms of the innate antiviral immunity are discussed and treatment regimens are proposed. The complex of native cytokines and antimicrobial peptides (CCAP or Superlymph) proved to inhibit the virus reproduction in vitro. Protegrines, as a CCAP component, were active against the virus. Considering all the data, we conclude that the complex of native cytokines and antimicrobial peptides produces both immunomodulating and antiviral effects.

0 0

Post a comment